Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial. (Q43765205)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Marcello Deraco

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Shigeki Kusamura

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

5

object named as

Antonio Macrì

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Salvatore Virzì

3

object named as

Salvatore Virzì

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

8

object named as

Serena Bonomi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Domenico Rosario Iusco

9

object named as

Domenico Rosario Iusco

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Francesco Puccio

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Ciro Famulari

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Massimiliano Solazzo

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

0 references

publication date

12 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

122

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

215-220

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Interval debulking surgery for advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

The role of maintenance therapy and novel taxanes in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer: A critical need for an evidence-based evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Peritonectomy procedures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

"Optimal" cytoreduction for advanced epithelial ovarian cancer: a commentary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Advanced cytoreductive surgery in gynecologic oncology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Intraperitoneal therapy for ovarian cancer: why has it not become standard?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.004

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.05.004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21665254%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43765205&oldid=2103142491"